Overview

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
This study was planned to evaluate the efficacy and safety of combination therapy of Immuncell-LC and nivolumab in patients with relapsed or advanced gastric adenocarcinoma or gastro-esophageal junction cancer.
Phase:
N/A
Details
Lead Sponsor:
Gangnam Severance Hospital